We are live on ! Find out more
QCOR

QUESTCOR PHARMA INC
QCOR

Delisted

QCOR was delisted on the 14th of August, 2014.

313 hedge funds and large institutions have $4.06B invested in QUESTCOR PHARMA INC in 2014 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 102 increasing their positions, 125 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 29

18% more capital invested

Capital invested by funds: $3.44B → $4.06B (+$616M)

14% more funds holding in top 10

Funds holding in top 10: 78 (+1)

10% more funds holding

Funds holding: 285313 (+28)

18% less repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 125

44% less call options, than puts

Call options by funds: $256M | Put options by funds: $455M

Holders
313
Holders Change
+28
Holders Change %
+9.82%
% of All Funds
9.04%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.23%
New
58
Increased
102
Reduced
125
Closed
29
Calls
$256M
Puts
$455M
Net Calls
-$199M
Net Calls Change
+$34.1M
Name Holding Trade Value Shares
Change
Change in
Stake
DADC
176
D.A. Davidson & Co
Montana
$1.47M -$1.53K -24 -0.1%
SCM
177
Sterling Capital Management
North Carolina
$1.43M +$1.41M +22,057 New
Zurich Cantonal Bank
178
Zurich Cantonal Bank
Switzerland
$1.43M -$511K -8,000 -27%
TRSOTSOK
179
Teachers Retirement System of the State of Kentucky
Kentucky
$1.42M
STC
180
SEI Trust Company
Pennsylvania
$1.41M +$226K +3,541 +19%
RFC
181
Regions Financial Corp
Alabama
$1.38M +$242K +3,796 +22%
Thrivent Financial for Lutherans
182
Thrivent Financial for Lutherans
Minnesota
$1.32M -$8.1M -126,850 -86%
AI
183
Analytic Investors
California
$1.29M -$52.2K -817 -4%
BJ
184
BlackRock Japan
Japan
$1.24M -$57.3K -898 -4%
VanEck Associates
185
VanEck Associates
New York
$1.21M +$469K +7,341 +65%
FCBT
186
First Citizens Bank & Trust
North Carolina
$1.19M -$64 -1 -0%
PA
187
Profund Advisors
Maryland
$1.13M -$265K -4,148 -19%
PTC
188
Philadelphia Trust Company
Pennsylvania
$1.08M +$1.06M +16,650 New
Public Employees Retirement Association of Colorado
189
Public Employees Retirement Association of Colorado
Colorado
$1.07M
FA
190
FDx Advisors
Illinois
$1.07M +$372K +5,823 +55%
Creative Planning
191
Creative Planning
Kansas
$1.06M +$149K +2,333 +17%
CCI
192
Columbus Circle Investors
$1.04M +$302K +4,724 +42%
HighTower Advisors
193
HighTower Advisors
Illinois
$1.04M +$534K +8,364 +110%
N
194
Natixis
France
$1.02M +$62K +971 +7%
GF
195
Gerstein Fisher
New York
$975K +$293K +4,594 +44%
GH
196
GAM Holding
Switzerland
$974K +$958K +15,000 New
SKK
197
Shepherd Kaplan Krochuk
Massachusetts
$963K +$85K +1,332 +10%
AG
198
Algert Global
California
$956K -$199K -3,112 -17%
PI
199
PineBridge Investments
New York
$907K -$86.7K -1,358 -9%
HFS
200
HL Financial Services
Kentucky
$878K -$31.1K -487 -3%

QCOR Hedge Fund Activity: Q1 2014 in Review

313 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in QUESTCOR PHARMA INC (QCOR) for Q1 2014, worth a combined $4.06B — up 18% from $3.44B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new QCOR positions and 29 closed out — a net gain of 29 holders — while 102 added to existing stakes and 125 trimmed.

The largest buyer was Fidelity International, opening a new position worth an estimated $46.5M. The largest seller was Fidelity Investments, cutting an estimated $93.3M.

  • 313 institutional investors held QUESTCOR PHARMA INC (QCOR) as of Q1 2014, up from 285 in Q4 2013.
  • Funds reported $4.06B of QUESTCOR PHARMA INC stock for Q1 2014, up 18% quarter-over-quarter.
  • 58 funds opened new QUESTCOR PHARMA INC positions in Q1 2014 and 29 closed out, a net change of +29 holders.
  • The largest QUESTCOR PHARMA INC buyer in Q1 2014 was Fidelity International, an estimated $46.5M added.
  • The largest QUESTCOR PHARMA INC seller in Q1 2014 was Fidelity Investments, an estimated $93.3M sold.

Based on aggregated 13F filings for Q1 2014.